| Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. RLM de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de ... Hypertension 53 (3), 466-72., 2009 | 486 | 2009 |
| Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study. RLM de la Sierra A, Banegas JR, Segura J, Gorostidi M, CE Investigators. J Hypertens. 4, 713-9, 2012 | 173* | 2012 |
| Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study D Orozco-Beltran, VF Gil-Guillen, J Redon, JM Martin-Moreno, ... PLoS One 12 (10), e0186196, 2017 | 130 | 2017 |
| La consulta telemática para el cardiólogo clínico en tiempos de la COVID-19: presente y futuro. Documento de consenso de la Sociedad Española de Cardiología V Barrios, J Cosín-Sales, M Bravo, C Escobar, JM Gámez, A Huelmos, ... Revista Española de Cardiología 73 (11), 910-918, 2020 | 65 | 2020 |
| COVID-19 y enfermedad cardiovascular y renal:¿ Dónde estamos?¿ Hacia dónde vamos? VP Carratalá, C Górriz-Zambrano, CM Ariño, JLL Caro, JL Górriz Medicina de Familia. SEMERGEN 46, 78-87, 2020 | 52 | 2020 |
| Plyometric muscular action tests in judo-and non-judo athletes LF Monteiro, LM Massuça, JG García, V Carratala, J Proença Isokinetics and exercise science 19 (4), 287-293, 2011 | 52 | 2011 |
| Percepción del entorno deportivo juvenil por deportistas, padres, entrenadores y gestores V Carratalà, M Gutiérrez, JF Guzmán, C Pablos Revista de psicología del deporte 20 (2), 337-352, 2011 | 49 | 2011 |
| Telemedicine consultation for the clinical cardiologists in the era of COVID-19: present and future. Consensus document of the Spanish Society of Cardiology V Barrios, J Cosín-Sales, M Bravo, C Escobar, JM Gámez, A Huelmos, ... Revista Española de Cardiología (English Edition) 73 (11), 910-918, 2020 | 46 | 2020 |
| Características basales y manejo clínico de los primeros 3.000 pacientes incluidos en el estudio IBERICAN (Identificación de la población española de riesgo cardiovascular y renal) SC Sanjurjo, MÁP Díaz, JLL Caro, VP Carratalá, AB García, LR Padial, ... SEMERGEN-Medicina de Familia 43 (7), 493-500, 2017 | 45* | 2017 |
| Objetivos y manifestación de valores sociales y personales en el deporte juvenil según deportistas, padres, entrenadores y gestores M Gutiérrez Sanmartín, V Carratalá Deval, JF Guzmán Luján, ... Apunts. Educació física i esports, 2010 | 44 | 2010 |
| Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain Z Perseguer-Torregrosa, D Orozco-Beltrán, VF Gil-Guillen, ... Journal of Managed Care Pharmacy 20 (12), 1217-1225, 2014 | 41 | 2014 |
| Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension. RJ Fácila L, Pallarés V, Peset A, Pérez M, Gil V, Montagud V, Bellido V ... Blood Press 19 (2), 104-9., 2010 | 33* | 2010 |
| Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. RJ Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R ... Drugs Aging 28 (12), 981-92, 2011 | 32 | 2011 |
| Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. RL Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-Pérez ... BMC Public Health. 22 (10), 717, 2010 | 32* | 2010 |
| Is the physician’s behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study A Palazon-Bru, VF Gil-Guillen, D Orozco-Beltran, V Pallares-Carratala, ... PLoS One 9 (3), e91567, 2014 | 31 | 2014 |
| Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias V Pallarés-Carratalá, V Pascual-Fuster, D Godoy-Rocatí SEMERGEN-Medicina de Familia 41 (8), 435-445, 2015 | 30 | 2015 |
| La pandemia por la COVID-19: una oportunidad para cambiar la forma de atender a nuestros pacientes VP Carratalá, C Górriz-Zambrano, JLL Caro, JL Górriz Semergen 46, 3, 2020 | 27 | 2020 |
| Clinical experience with diltiazem in the treatment of cardiovascular diseases L Rodriguez Padial, G Baron-Esquivias, A Hernandez Madrid, ... Cardiology and Therapy 5, 75-82, 2016 | 27* | 2016 |
| Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to as certain reasons for not intensifying treatment. RJ Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E ... Am J Cardiovasc Drugs. 13 (3), 213-9, 2013 | 27 | 2013 |
| Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial. BV Morillas P, Pallarés V, Llisterri JL, Sanchis C, Sánchez T, Fácila L ... Rev Esp Cardiol 63 (8), 943-50., 2010 | 27* | 2010 |
